Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CA5A | P35218 | 2/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | NT5E | P21589 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27569711 | 0.96 | CA2 (0.41) | CA2TSHRTDP1CA5ACA5B | |
| SCHEMBL28306618 | 0.96 | CA2 (0.41) | CA2TSHRTDP1CA5ACA5B | |
| SCHEMBL3604944 | 0.96 | CA2 (0.41) | CA2TSHRTDP1CA5ACA5B | |
| SCHEMBL15231029 | 0.96 | CA2 (0.41) | CA2TSHRTDP1CA5ACA5B | |
| SCHEMBL1536035 | 0.96 | CA2 (0.41) | CA2TSHRTDP1CA5ACA5B | |
| SCHEMBL23880589 | 0.96 | CA2 (0.41) | CA2TSHRTDP1CA5ACA5B | |
| SCHEMBL8068395 | 0.96 | CA2 (0.41) | CA2TSHRTDP1CA5ACA5B | |
| SCHEMBL7777376 | 0.96 | CA2 (0.41) | CA2TSHRTDP1CA5ACA5B | |
| SCHEMBL9778121 | 0.96 | CA2 (0.41) | CA2TSHRTDP1CA5ACA5B | |
| SCHEMBL28142764 | 0.96 | CA2 (0.41) | CA2TSHRTDP1CA5ACA5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024123962-A1 | PROCESS FOR PRODUCING SULFATE OF POTASH FROM A WOOD PULPING OPERATION | VEOLIA WATER TECHNOLOGIES, INC. (US) | 2024-06-13 | — | — | WO | claimed |
| US-11894524-B2 | Positive electrode plate, and electrochemical apparatus and device associated therewith | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2024-02-06 | — | — | US | claimed |
| US-20230383080-A1 | Compositions and Foam Compositions Containing Composite Particles, Articles, Composite Particles, and Methods | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-11-30 | — | — | US | claimed |
| EP-3979397-B1 | POSITIVE ELECTRODE PLATE AND ELECTROCHEMICAL DEVICE AND EQUIPMENT ASSOCIATED THEREWITH | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2023-09-06 | — | — | EP | claimed |
| US-20220158257-A1 | POSITIVE ELECTRODE PLATE, AND ELECTROCHEMICAL APPARATUS AND DEVICE ASSOCIATED THEREWITH | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2022-05-19 | — | — | US | claimed |
| CN-109761405-B | Comprehensive recovery and zero-discharge process of sulfate carbonate binary system high-salt nickel-containing wastewater | 浙江科菲科技股份有限公司 | 2021-11-16 | — | — | CN | claimed |
| CN-110429240-B | Positive pole piece and electrochemical device comprising same | 宁德时代新能源科技股份有限公司 | 2020-12-04 | — | — | CN | claimed |
| CN-109761405-A | A kind of synthetical recovery of sulfate carbonate binary system nickel-containing waste water with high salt and the technique of wastewater zero discharge | 浙江科菲科技股份有限公司 | 2019-05-17 | — | — | CN | claimed |
| CN-108913293-A | A kind of ship-used rust-proof lubricating oil | 张彩萍 | 2018-11-30 | — | — | CN | claimed |
| CN-108410230-A | A kind of heat-insulated paint | 南通森德诺家纺科技有限公司 | 2018-08-17 | — | — | CN | claimed |
| US-20140087059-A1 | PHARMACEUTICAL COMPOSITION AND PROCESS FOR MONTELUKAST TABLETS | PHARMA PASS LLC (US) | 2014-03-27 | — | — | US | claimed |
| US-20100267552-A1 | Sulfur tolerant alumina catalyst support | W. R. GRACE & CO.-CONN. | 2010-10-21 | — | — | US | claimed |
| US-20100143473-A1 | COMBINATION TREATMENT WITH STRONTIUM FOR THE PROPHYLAXIS AND/OR TREATMENT OF CARTILAGE AND/OR BONE CONDITIONS | OSTEOLOGIX A/S | 2010-06-10 | — | — | US | claimed |
| EP-2081681-A1 | SULFUR TOLERANT ALUMINA CATALYST SUPPORT | W. R. Grace & Co.-Conn (US) | 2009-07-29 | — | — | EP | claimed |
| WO-2008045175-A1 | SULFUR TOLERANT ALUMINA CATALYST SUPPORT | W.R. GRACE & CO. - CONN. (US) | 2008-04-17 | — | — | WO | claimed |
| CN-1981594-A | Method for preparing complex of feed additive | WANG QUANYI (CN) | 2007-06-20 | — | — | CN | claimed |
| US-20060275503-A1 | Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions | NORDIC BONE A/S (DK) | 2006-12-07 | — | — | US | claimed |
| EP-1622630-A2 | STRONTIUM COMBINATIONS FOR THE PROPHYLAXIS/TREATMENT OF CARTILAGE AND/OR BONE CONDITIONS | Osteologix A/S (DK) | 2006-02-08 | — | — | EP | claimed |
| WO-2004098618-A2 | STRONTIUM COMBINATIONS FOR PROPHYLAXIS/TREATMENT OF CARTILAGE AND/OR BONE CONDITIONS | OSTEOLOGIX A/S (DK) | 2004-11-18 | — | — | WO | claimed |
| EP-0007260-B1 | PROCESS FOR THE PREPARATION OF METALLIFEROUS DETERGENT-DISPERSANT ADDITIVES OF HIGH ALKALI CONTENT, ESPECIALLY FOR LUBRICATING OILS, AND PRODUCT OBTAINED | OROGIL (FR) | 1981-09-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140087059-A1 | PHARMACEUTICAL COMPOSITION AND PROCESS FOR MONTELUKAST TABLETS | CMA1, MASTL, MAST3 | CA2 741/4885TSHR 4420/4885TDP1 4680/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.